[go: up one dir, main page]

SE424637B - Analogiforfarande for framstellning av pyridylguanidiner med terapeutisk verkan - Google Patents

Analogiforfarande for framstellning av pyridylguanidiner med terapeutisk verkan

Info

Publication number
SE424637B
SE424637B SE7514153A SE7514153A SE424637B SE 424637 B SE424637 B SE 424637B SE 7514153 A SE7514153 A SE 7514153A SE 7514153 A SE7514153 A SE 7514153A SE 424637 B SE424637 B SE 424637B
Authority
SE
Sweden
Prior art keywords
pyridylguanidines
preparation
therapeutical effect
analogy procedure
analogy
Prior art date
Application number
SE7514153A
Other languages
English (en)
Swedish (sv)
Other versions
SE7514153L (sv
Inventor
H J Petersen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE7514153L publication Critical patent/SE7514153L/xx
Publication of SE424637B publication Critical patent/SE424637B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE7514153A 1974-12-20 1975-12-15 Analogiforfarande for framstellning av pyridylguanidiner med terapeutisk verkan SE424637B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55209/74A GB1489879A (en) 1974-12-20 1974-12-20 N'-cyano-n'-3-pyridylguanidines

Publications (2)

Publication Number Publication Date
SE7514153L SE7514153L (sv) 1976-06-21
SE424637B true SE424637B (sv) 1982-08-02

Family

ID=10473276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7514153A SE424637B (sv) 1974-12-20 1975-12-15 Analogiforfarande for framstellning av pyridylguanidiner med terapeutisk verkan

Country Status (22)

Country Link
US (2) US4057636A (de)
JP (1) JPS6028819B2 (de)
AT (1) AT346357B (de)
BE (1) BE836885A (de)
CA (1) CA1067083A (de)
CH (1) CH618429A5 (de)
DD (1) DD122529A5 (de)
DE (2) DE2557438A1 (de)
DK (1) DK145341C (de)
ES (1) ES443725A1 (de)
FI (1) FI60560C (de)
FR (1) FR2294703A1 (de)
GB (1) GB1489879A (de)
IE (1) IE42141B1 (de)
IT (1) IT1062213B (de)
LU (1) LU74071A1 (de)
NL (1) NL184109C (de)
PH (1) PH12506A (de)
SE (1) SE424637B (de)
SU (1) SU683615A3 (de)
YU (1) YU39754B (de)
ZA (1) ZA757481B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562066A (en) * 1978-11-03 1980-05-10 Toshihiko Okamoto N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
IE52935B1 (en) * 1981-04-15 1988-04-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE54196B1 (en) * 1981-09-10 1989-07-19 Leo Pharm Prod Ltd Chemical compounds
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
EP0579260A1 (de) * 1987-07-07 1994-01-19 Beecham Group Plc Verwendung eines Vasodilators zur Behandlung von pulmonalem Bluthochdruck und/oder Rechtsherzversagen relatierten Krankheiten
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
US5244664A (en) * 1988-01-21 1993-09-14 Leo Pharmaceutical Products Ltd. Topical preparation for treatment of alopecia
AU3693789A (en) * 1988-05-10 1989-11-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) New ophthalmic preparation for treating glaucoma
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
JP2884412B2 (ja) * 1988-10-21 1999-04-19 日本バイエルアグロケム株式会社 殺虫性シアノ化合物
AU623217B2 (en) * 1989-02-03 1992-05-07 Eli Lilly And Company (-)-n"-cyano-n-3-pyridyl-n'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament
US5264445A (en) * 1989-02-03 1993-11-23 Eli Lilly And Company (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine
EP0407346A3 (en) * 1989-07-07 1991-10-02 Ciba-Geigy Ag Aminopyridines
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5217982A (en) * 1990-09-25 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive properties
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
DE69218246T2 (de) * 1991-12-23 1997-07-17 Pharmacia & Upjohn Co., Kalamazoo, Mich. Pyridylguanidine verbindungen zur behandlung von erektionsstörungen
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH06228100A (ja) * 1992-12-07 1994-08-16 Green Cross Corp:The 光学活性アミノピリジン誘導体およびその用途
WO1994029280A1 (en) * 1993-06-11 1994-12-22 The Upjohn Company Pyrimidine cyanoguanidines as k-channel blockers
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5633374A (en) * 1993-11-26 1997-05-27 The Upjohn Company Pyrimidine, cyanoguanidines as K-channel blockers
JPH09508382A (ja) * 1994-01-28 1997-08-26 ジ・アップジョン・カンパニー Ｋ−チャネル遮断薬用シアノグアニジン類
US5525742A (en) * 1994-06-10 1996-06-11 The Upjohn Company Azidophenylcyanoguanidines as photoaffinity probes
US5856449A (en) * 1994-11-17 1999-01-05 Pharmacia & Upjohn Company Protein affecting KATP channels
US6335352B1 (en) * 1996-08-15 2002-01-01 Smithkline Beecham Corporation IL-8 receptor antagonists
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
US6013668A (en) 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
WO1999011621A2 (en) * 1997-09-03 1999-03-11 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
US6255323B1 (en) 1999-04-09 2001-07-03 Shionogi Bioresearch Corp. Cyanoguanidine compounds
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
JP4690889B2 (ja) * 2002-10-24 2011-06-01 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング メチレン尿素誘導体
EP1917244A2 (de) * 2005-08-24 2008-05-07 Abbott GmbH & Co. KG Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
US20070250567A1 (en) * 2006-04-20 2007-10-25 Graham Philip R System and method for controlling a telepresence system
WO2009089053A1 (en) * 2008-01-11 2009-07-16 Nektar Therapeutics Al, Corporation Oligomer-guanidine class conjugates
US9102659B2 (en) 2010-12-09 2015-08-11 Radikal Therapeutics Inc. Multifunctional nitroxide derivatives and uses thereof
US20220324809A1 (en) * 2019-09-03 2022-10-13 Salzman Group Ltd. Atp-regulated potassium channel openers and uses thereof
WO2023176554A1 (ja) * 2022-03-14 2023-09-21 国立大学法人東北大学 認知機能改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036083A (en) * 1959-05-15 1962-05-22 Ciba Geigy Corp Certain 2-pyridyl lower alkyl guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Also Published As

Publication number Publication date
JPS5186474A (de) 1976-07-29
CH618429A5 (de) 1980-07-31
FI753520A (de) 1976-06-21
DK145341C (da) 1983-03-28
IE42141B1 (en) 1980-06-04
DE2560633C2 (de) 1988-09-08
ATA936075A (de) 1978-03-15
NL7514852A (nl) 1976-06-22
FI60560C (fi) 1982-02-10
ZA757481B (en) 1977-01-26
JPS6028819B2 (ja) 1985-07-06
USRE31244E (en) 1983-05-17
DE2557438C2 (de) 1989-01-05
DD122529A5 (de) 1976-10-12
IT1062213B (it) 1983-09-20
YU39754B (en) 1985-04-30
SE7514153L (sv) 1976-06-21
IE42141L (en) 1976-06-20
DK145341B (da) 1982-11-01
FR2294703B1 (de) 1980-06-27
PH12506A (en) 1979-04-18
SU683615A3 (ru) 1979-08-30
LU74071A1 (de) 1976-11-11
FI60560B (fi) 1981-10-30
CA1067083A (en) 1979-11-27
AU8712775A (en) 1977-06-09
GB1489879A (en) 1977-10-26
AT346357B (de) 1978-11-10
NL184109B (nl) 1988-11-16
YU316275A (en) 1982-02-28
NL184109C (nl) 1989-04-17
US4057636A (en) 1977-11-08
BE836885A (fr) 1976-06-21
FR2294703A1 (fr) 1976-07-16
DE2557438A1 (de) 1976-06-24
DK572975A (da) 1976-06-21
ES443725A1 (es) 1977-04-16

Similar Documents

Publication Publication Date Title
SE424637B (sv) Analogiforfarande for framstellning av pyridylguanidiner med terapeutisk verkan
SE420921B (sv) Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan
SE412906B (sv) Forfarande for framstellning av 3-aryloxi-3-fenylpropylaminer med farmakologisk verkan
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE425790B (sv) Forfarande for framstellning av polylaurinlactam
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE7514308L (sv) Forfarande for framstellning av tyrosinderivat med terapeutisk verkan
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
SE7512292L (sv) Forfarande for framstellning av naftalenforeningar med terapeutisk verkan
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE414028B (sv) Forfarande for framstellning av terapeutisk verksamma fentiazinderivat
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE7507887L (sv) Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan.
NO149775C (no) Analogifremgangsmaate for fremstilling av fenyl-pyridylamin-derivater med antidepressiv virkning
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7514153-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7514153-1

Format of ref document f/p: F